Oncolytics Biotech (ONCY) Tops Q1 EPS by 3c

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ
• OpenAI launches cybersecurity tools and open-source patching program